Notice of Privacy Incident
Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.

Drugs and Therapeutics (D & T) Committee Meeting Results for: September 24, 2008

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Patanase	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Requip XL	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Required
Bystolic	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Evamist	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Required
Zamicet	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Treximet	New Drug Appeal	Require Prior Approval	Prior Approval Required
Cimzia	New Drug Appeal	Require Prior Approval	Prior Approval Required
Suprax Suspension	PDL Appeal	Removed from Agenda	Prior Approval Required
Symbicort	PDL Appeal	Require Prior Approval	Prior Approval Required
Baraclude	PDL Appeal	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Vytorin	PDL Appeal	Require Prior Approval	Prior Approval Required

Footer